Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Executive Officer, Director
-
Stock Symbol
-
RXRX on Nasdaq
Christopher Gibson - trading volume in the past year for Recursion Pharmaceuticals, Inc.
Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Class A Common Stock |
1.12M |
$6.75M |
$6.04 |
Mar 27, 2025 |
Direct |
|
|
Class B Common Stock |
5.9M |
|
|
Mar 27, 2025 |
Direct |
Class A Common Stock |
5.9M |
Class B Common Stock |
486K |
|
|
Mar 27, 2025 |
by LAHWRAN-3 LLC |
Class A Common Stock |
0 |
Class B Common Stock |
388K |
|
|
Mar 27, 2025 |
by LAHWRAN-4 LLC |
Class A Common Stock |
0 |
Stock Option (Right to Buy) |
283K |
|
|
Mar 27, 2025 |
Direct |
Class A Common Stock |
0 |
Class B Common Stock |
67.9K |
|
|
Mar 27, 2025 |
by Gibson Family Trust |
Class A Common Stock |
0 |
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.